All OpportunitiesView on Grants.gov
HRSA
HRSA-26-052
discretionary
Forecasted
Sickle Cell Disease Regional Care Excellence (SoRCE) Program
Health Resources and Services AdministrationCloses May 31, 2026Posted December 11, 2025
Official Federal Notice
View the complete notice on Grants.gov
Summary
Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD. Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment. As these children become adolescents and transition to...
Read full notice on Grants.govEligible Applicants
- Other
- Private institutions of higher education
- Public institutions of higher education
Additional Eligibility Details
Hospitals or clinicsHealth centers.Documentation must be provided to demonstrate that your organization has at least five years of experience in working with individuals who have sickle cell disease (SCD).
Assistance Listings
93.365
Sickle Cell Treatment Demonstration ProgramFunding Instrument
Cooperative Agreement
CFDA / Assistance Listing Numbers
93.365
Topics
Program Contact
Information on this page is sourced from official federal notices on Grants.gov. Always verify eligibility, deadlines, and requirements using the official notice. Funding Radar is not affiliated with the U.S. government.
Key Details
Award Ceiling
$950,000
Total Program Funding
$6,650,000
Expected Awards
7
Posted
December 11, 2025
Deadline
May 31, 2026
68 days remaining
Cost Sharing
Not Required
Agency
HRSA
Data from Grants.gov
Last fetched: 3/23/2026